Aspyra

APYI

Medical - Healthcare Information Services · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$34

Winston Score

Winston is serious

Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+274.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 33K (2004) → 123K (2008)

Aspyra Inc. is a small healthcare technology company that makes software for medical facilities. Its core products are information systems used by hospitals, clinics, and diagnostic imaging centers to manage patient records, orders, and test results. The company operates in the healthcare information services industry, focusing on tools that help medical staff organize and share clinical data.

Aspyra earns revenue primarily by selling software licenses and providing related support and maintenance services to its healthcare customers, which gives it a recurring revenue component. The company is small, with a market cap near zero, and operates mainly in the United States. Its gross and operating margins are relatively high for its size, suggesting low variable costs once software is deployed, but being a very small player in a market dominated by much larger vendors like Epic and Oracle Health is a significant competitive risk. The main challenge Aspyra faces is winning and keeping customers against well-funded rivals with broader product offerings.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-16.9% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-59.6% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$2M/ year

↓ Declining (-22% vs prior year)

21.4% of revenue

In line with sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

36.9%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~4 months

$564,862 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Aspyra has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

37.6%

Modest — 37.6% gross margin

Operating Margin

56.2%

Excellent — 56.2% operating margin

ROCE

11.9%

Below par — 11.9% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-15.6%

Shrinking sales (-15.6% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-30.7%

Burning cash (-30.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

1.04

Elevated debt (1.04)

Interest Cover

4.05x

Adequate interest coverage (4.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial